PART I Overview We are a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patients own anatomy. Our growing product portfolio is purposefully designed to leverage the patients natural healing response while minimizing long-term exposure to permanent synthetic materials. We are committed to delivering our advanced technologies with a strong econom...
Q2 FY2026 — expected 2026-08-11
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | TELA | discussed_in_filing Cybersecurity | |
| topic_mention | TELA | discussed_in_filing Trusted Computing | |
| topic_mention | TELA | discussed_in_filing Blockchain & Crypto | |
| topic_mention | TELA | discussed_in_filing Robotics | |
| topic_mention | TELA | discussed_in_filing Supply Chain | |
| topic_mention | TELA | discussed_in_filing Regulation | |
| topic_mention | TELA | discussed_in_filing Healthcare & Bio | |
| topic_mention | TELA | discussed_in_filing AI Compute | |
| topic_mention | TELA | discussed_in_filing Sovereign & Government | |
| topic_mention | TELA | discussed_in_filing Cybersecurity | |
| topic_mention | TELA | discussed_in_filing Trusted Computing | |
| topic_mention | TELA | discussed_in_filing Blockchain & Crypto | |
| topic_mention | TELA | discussed_in_filing Robotics | |
| topic_mention | TELA | discussed_in_filing Supply Chain | |
| topic_mention | TELA | discussed_in_filing Regulation | |
| topic_mention | TELA | discussed_in_filing Healthcare & Bio | |
| topic_mention | TELA | discussed_in_filing AI Compute | |
| topic_mention | TELA | discussed_in_filing Sovereign & Government | |
| topic_mention | TELA | discussed_in_filing Cybersecurity | |
| topic_mention | TELA | discussed_in_filing Trusted Computing |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-25 | 2025-12-31 | 0001104659-26-034507 | EDGAR | 86K words |
| 2025-03-21 | 2024-12-31 | 0001558370-25-003460 | EDGAR | — |
| 2024-03-22 | 2023-12-31 | 0001558370-24-003782 | EDGAR | — |
| 2023-03-23 | 2022-12-31 | 0001558370-23-004468 | EDGAR | — |
| 2022-03-23 | 2021-12-31 | 0001558370-22-004151 | EDGAR | — |
| 2021-03-25 | 2020-12-31 | 0001558370-21-003483 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001558370-20-003346 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001104659-25-112476 | EDGAR | 21K words |
| 2025-08-11 | 2025-06-30 | 0001558370-25-011052 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001558370-25-006994 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001558370-24-015050 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001558370-24-012060 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001558370-24-007784 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001558370-23-018822 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001558370-23-014494 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001558370-23-009426 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001558370-22-017464 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001558370-22-013286 | EDGAR | — |
| 2022-05-11 | 2022-03-31 | 0001558370-22-008301 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-24 | 0001104659-26-033839 | EDGAR | 3K words |
| 2026-03-20 | 0001104659-26-032697 | EDGAR | — |
| 2025-11-14 | 0001104659-25-112653 | EDGAR | — |
| 2025-11-13 | 0001104659-25-111285 | EDGAR | — |
| 2025-11-03 | 0001104659-25-105548 | EDGAR | — |
| 2025-10-09 | 0001104659-25-098354 | EDGAR | — |
| 2025-08-11 | 0001104659-25-076153 | EDGAR | — |
| 2025-06-02 | 0001104659-25-055248 | EDGAR | — |
| 2025-05-30 | 0001104659-25-054867 | EDGAR | — |
| 2025-05-08 | 0001104659-25-046124 | EDGAR | — |
129 total filings indexed. 100 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001561921 |
| Ticker | TELA |
| Exchange | Nasdaq |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report